Abstract:A new "branch" for polyketide synthases was discovered in the biosynthesis of the antimitotic rhizoxin complex in the endofungal bacterium Burkholderia rhizoxinica. Genetic engineering and the structural elucidation of pathway intermediates revealed that a complex polyketide chain is branched at the beta position by an unprecedented conjugate addition of an acetyl building block to an acryloyl precursor (see scheme).
“…An alternative b-branching mechanism has recently been described by Hertweck and coworkers for the rhizoxin trans-AT PKS [165]. Most rhizoxins, such as 47 or rhizoxin A (13), carry an unusual b-branched d-lactone moiety (Fig.…”
Section: Chain Branching By Michael Addition (B Domains)mentioning
confidence: 96%
“…To dissect the b-branching process via the same approach as described in Sect. 4.1, the TE domain was inactivated to promote release of individual intermediates [165]. The compounds were identified as the free acids of 60-62, which excluded an isoprenoidlike pathway starting from a b-keto precursor.…”
Section: Chain Branching By Michael Addition (B Domains)mentioning
confidence: 99%
“…A different approach was used to study double bond formation in bacillaene (2) [26] and rhizoxin D (47) [153] biosynthesis. Piel and coworkers observed that inactivation of the TE domain in the bacillaene (2) trans-AT system resulted in the hydrolytic release of virtually all polyketide intermediates from the PKS [23].…”
Section: Introduction Of Shifted Double Bondsmentioning
Bacterial multimodular polyketide synthases (PKSs) are responsible for the biosynthesis of a wide range of pharmacologically active natural products. These megaenzymes contain numerous catalytic and structural domains and act as biochemical templates to generate complex polyketides in an assembly line-like fashion. While the prototypical PKS is composed of only a few different domain types that are fused together in a combinatorial fashion, an increasing number of enzymes is being found that contain additional components. These domains can introduce remarkably diverse modifications into polyketides. This review discusses our current understanding of such noncanonical domains and their role in expanding the biosynthetic versatility of bacterial PKSs.
“…An alternative b-branching mechanism has recently been described by Hertweck and coworkers for the rhizoxin trans-AT PKS [165]. Most rhizoxins, such as 47 or rhizoxin A (13), carry an unusual b-branched d-lactone moiety (Fig.…”
Section: Chain Branching By Michael Addition (B Domains)mentioning
confidence: 96%
“…To dissect the b-branching process via the same approach as described in Sect. 4.1, the TE domain was inactivated to promote release of individual intermediates [165]. The compounds were identified as the free acids of 60-62, which excluded an isoprenoidlike pathway starting from a b-keto precursor.…”
Section: Chain Branching By Michael Addition (B Domains)mentioning
confidence: 99%
“…A different approach was used to study double bond formation in bacillaene (2) [26] and rhizoxin D (47) [153] biosynthesis. Piel and coworkers observed that inactivation of the TE domain in the bacillaene (2) trans-AT system resulted in the hydrolytic release of virtually all polyketide intermediates from the PKS [23].…”
Section: Introduction Of Shifted Double Bondsmentioning
Bacterial multimodular polyketide synthases (PKSs) are responsible for the biosynthesis of a wide range of pharmacologically active natural products. These megaenzymes contain numerous catalytic and structural domains and act as biochemical templates to generate complex polyketides in an assembly line-like fashion. While the prototypical PKS is composed of only a few different domain types that are fused together in a combinatorial fashion, an increasing number of enzymes is being found that contain additional components. These domains can introduce remarkably diverse modifications into polyketides. This review discusses our current understanding of such noncanonical domains and their role in expanding the biosynthetic versatility of bacterial PKSs.
“…However, neither the expected macrolides nor biosynthetic [38,39] could be detected by LC-HRMS. This finding strongly suggests that the rhi PKS module 1 does not accept heterocycles with nitrogen atoms that do not donate their lone-pair electrons into the ring, regardless of the position(s) and number of the nitrogens.…”
Chain armor against tumor cells: The oxazole side chain in the antimitotic agent rhizoxin S2 (1) was successfully replaced through mutasynthesis by using an engineered mutant impaired in heterocyclization. Incorporation of 12 non-natural surrogates into fully processed rhizoxin analogues revealed a remarkable substrate flexibility of the PKS-NRPS hybrid.
“…This observation leads us to re-assess the principal role of AHs in PKS assembly lines as housekeeper enzymes, serving to hydrolyse erroneously loaded acetyl groups on ACPs. It should be pointed out that previous work on bacillaene and rhizoxin PKS possessing inactivated terminal thioesterase domains showed that short-and long-chain intermediates were hydrolysed off the PKS in cells [34][35][36] . This finding might be due to an additional proofreading activity present in these pathways, a different activity profile of the cognate AHs, or simply base-catalysed hydrolysis.…”
Section: Please Do Not Adjust Margins Please Do Not Adjust Marginsmentioning
A note on versions:The version presented here may differ from the published version or from the version of record. If you wish to cite this item you are advised to consult the publisher's version. Please see the repository url above for details on accessing the published version and note that access may require a subscription.For more information, please contact eprints@nottingham.ac.uk
Journal Name
COMMUNICATIONThis journal is
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.